Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Clinical trial NCT04168203 · COMPLETED

Trial details

NCT number: NCT04168203
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Deep Vein Thrombosis Pulmonary Embolism Venous Thromboembolism

Start date: 2021-03-01
Primary completion: 2023-11-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.